Back
Spyre Therapeutics Stock Price Chart
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
Spyre Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.63 | Sell |
20-day SMA: | 34.16 | Sell |
50-day SMA: | 35.1 | Sell |
200-day SMA: | 24.22 | Buy |
8-day EMA: | 32.34 | Sell |
20-day EMA: | 33.91 | Sell |
50-day EMA: | 34.32 | Sell |
200-day EMA: | 27.18 | Sell |
Spyre Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -1780910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.05 - 37.75) | Sell |
Bollinger Bands (100): | (27.4 - 39.18) | Sell |
Spyre Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Spyre Therapeutics Stock
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 25.43 while SYRE 8-day simple moving average is 33.63, which is a Sell signal.
- The stock price of SYRE is 25.43 while Spyre Therapeutics 20-day SMA is 34.16, which makes it a Sell.
- Spyre Therapeutics 50-day simple moving average is 35.10 while SYRE share price is 25.43, making it a Sell technically.
- SYRE stock price is 25.43 and Spyre Therapeutics 200-day simple moving average is 24.22, creating a Buy signal.
SYRE Technical Analysis vs Fundamental Analysis
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy or a Sell?
-
Spyre Therapeutics stock is rated a Sell
The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Spyre Therapeutics Stock Info
Market Cap:
1.02B
Price in USD:
25.43
Share Volume:
2.77M
Spyre Therapeutics 52-Week Range
52-Week High:
47.97
52-Week Low:
2.66
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Spyre Therapeutics Share Price Forecast
-
What is the Spyre Therapeutics stock price today?
The Spyre Therapeutics stock price is 25.43 USD today. -
Will SYRE stock go up or go down?
Spyre Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Spyre Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Spyre Therapeutics is overvalued.
Is Spyre Therapeutics Stock a Buy?
- Spyre Therapeutics share price is 25.43 while SYRE 8-day exponential moving average is 32.34, which is a Sell signal.
- The stock price of SYRE is 25.43 while Spyre Therapeutics 20-day EMA is 33.91, which makes it a Sell.
- Spyre Therapeutics 50-day exponential moving average is 34.32 while SYRE share price is 25.43, making it a Sell technically.
- SYRE stock price is 25.43 and Spyre Therapeutics 200-day simple moving average is 27.18, creating a Sell signal.
Fundamental Analysis of Spyre Therapeutics
Is Spyre Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Technical Analysis of Spyre Therapeutics
Should I short Spyre Therapeutics stock?
- SYRE Moving Average Covergence Divergence (MACD) indicator is -1.04, suggesting Spyre Therapeutics is a Sell
- Spyre Therapeutics Relative Strength Index (RSI) is 31.35, which suggest Spyre Therapeutics is oversold
- The Bollinger Bands (25) for Spyre Therapeutics is (32.05 - 37.75), which suggest Spyre Therapeutics is a Sell
- The Bollinger Bands (100) for Spyre Therapeutics is (27.4 - 39.18), which suggest Spyre Therapeutics is a Sell
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.